New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 1, 2012
16:58 EDTHLF, PLXT, CHK, PFCB, SHLD, PBY, IDTI, PFEOn The Fly: Closing Wrap
Stocks on Wall Street were higher following an encouraging report on U.S. manufacturing. Stock futures were quiet during the pre-market trading session as investors digested the latest round of corporate earnings without having to deal with any new economic reports. The futures action led to a relatively quiet open for the broader market. The market received a lift following the ISM manufacturing report, which was better than expected. The data lifted to the market to fresh recovery highs on the Dow while recent highs were also within striking distance for the Nasdaq and S&P. The market met resistance at the new levels and pared its gains in the afternoon hours... ECONOMIC EVENTS: Domestically, the ISM manufacturing index rose to 54.8 in April, beating forecasts for a reading of 53.0. Construction spending for March increased by 0.1%, versus expectations of an increase of 0.5%. In China, the official purchasing managers’ index for manufacturing rose to 53.3 in April... COMPANY NEWS: Chesapeake (CHK) said it would appoint a new non-executive chairman in the near future to replace CEO Aubrey McClendon in that role. McClendon, who will remain on as CEO, also agreed to an early termination of the well participation program that has drawn a firestorm of recent backlash from media, investors and regulators. Shares gained $1.16, or 6.29%, to close at $19.60 ahead of the company's earnings report, due out after the bell... Dow component Pfizer (PFE) reported earnings that beat consensus but lowered its full year forecast to account for the divestiture of its Nutrition business... Sears Holdings (SHLD) gained $8.27, or 15.38%, to $62.05 after saying its Q1 domestic same store sales fell 1.3%, which was a significant improvement from the declines seen in the same period last year, and forecasting a return to earnings from continuing operations in the quarter... MAJOR MOVERS: Among the notable gainers were PLX Technology (PLXT), up $2.68, or 67.34%, to $6.66, after saying it will be acquired by Integrated Device Technology (IDTI) for $7 per share in cash and stock, and P.F. Chang's (PFCB), up $11.79, or 29.71%, to $51.48, on news it will be acquired and taken private by Centerbridge Partners for $51.50 per share in cash. Noteworthy losers included Herbalife (HLF), down $14.02, or 19.94%, to $56.30, after hedge fund manager and noted short-seller David Einhorn asked some critical questions during the company's earnings conference call, and Pep Boys (PBY), down $3.31, or 22.17%, to $11.62, after the Gores Group hinted it may attempt to walk away from its proposed $1B takeover of the company following Pep Boys' warning on its Q1 results... INDICES: The Dow gained 65.69, or 0.50%, to 13,279.32; the Nasdaq rose 4.08, or 0.13%, to 3,050.44; and the S&P 500 added 7.91, or 0.57%, to 1,405.82.
News For CHK;PFE;SHLD;PLXT;IDTI;PFCB;HLF;PBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 23, 2015
07:36 EDTPFEPfizer should rise 'significantly' over next two years, says Jefferies
Jefferies analyst Jeffrey Holford told investors this morning that he expects shares of Pfizer (PFE) to appreciate "significantly" over the next two years. A survey of U.S. oncologists indicated the company's Ibrance drug will be used in 50% of first line hormonal therapy within one year, with off-label use in all lines of therapy including adjuvant, Holford noted. He thinks peak sales of the drug could top $13B, which is well above consensus. In addition, the analyst views Pfizer's Global Established Pharmaceutical business as being underappreciated by the market. Potential value creating options for the pharmaceutical giant include spinning off its GEP unit by 2017 and accretive acquisitions, with possible takeover targets being Shire (SHPG), Actavis (ACT), AstraZeneca (AZN) and GlaxoSmithKline (GSK), in the eyes of Holford. He added the stock to the firm's Franchise Picks list, which encompasses its best ideas. He also raised his price target for Pfizer to $45 from $42. The stock closed Friday up 10c to $34.25.
March 20, 2015
15:45 EDTHLFHerbalife breaks above top of recent range, levels to watch
Shares have broken out of the top of the recent trading range at $40. This is bullish price behavior. At the current price of $40.79 next resistance is at $42. Support is at $40. It would be bearish for price if the stock resumes trading below the $40 area.
15:38 EDTHLFHerbalife volatility stays elevated on sharp rally
Subscribe for More Information
13:50 EDTHLFPershing Square corrects inaccurate press reports regarding Herbalife
Subscribe for More Information
13:03 EDTPFEPfizer says oral tofacitinib meets primary endpoint in Phase 3 trials
Subscribe for More Information
10:43 EDTCHKStocks with call strike movement; CHK FCX
Chesapeake (CHK) July 16 call option implied volatility increased 2% to 50, Freeport McMoRan (FCX) August 20 call option implied volatility decreased 6% to 47 according to IVolatility.
07:55 EDTPFEAstraZeneca seen as potential target again if oncology drugs lag, Bloomberg says
Subscribe for More Information
07:41 EDTPFEAmerican Academy of Dermatology to hold annual meeting
Subscribe for More Information
March 19, 2015
11:02 EDTHLFOptions with increasing implied volatility
Options with increasing implied volatility: HLF RAD NFLX HLSS NOW
11:00 EDTPFEPfizer participates in a conference call with Bernstein
Subscribe for More Information
10:02 EDTCHKOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTCHKOn The Fly: Pre-market Movers
Subscribe for More Information
08:24 EDTCHKChesapeake downgraded at Sterne Agee
Subscribe for More Information
06:20 EDTCHKChesapeake downgraded to Underperform from Neutral at Sterne Agee
March 18, 2015
17:09 EDTPFEPfizer CAPiTA published in New England Journal of Medicine
Subscribe for More Information
13:49 EDTHLFHerbalife says 'confident in strong fundamentals of business model'
Subscribe for More Information
12:35 EDTSHLDSears supply chain under pressure, WSJ says
Subscribe for More Information
09:23 EDTHLFOn The Fly: Pre-market Movers
Subscribe for More Information
08:02 EDTHLFHerbalife wins dismissal of class action 'pyramid scheme' lawsuit
On March 16, a judge in the U.S. District Court for the Central District of California granted Herbalife its motion to dismiss a class action complaint brought on behalf of shareholders who allege that the company and its executives violated federal securities laws by misrepresenting the "nature, scope and legality" of the company's business and operations. According to the plaintiffs, Herbalife and its executives, including CEO Michael Johnson, misrepresented Herbalife as a legitimate multi-level marketing company when it "is actually an illegal pyramid scheme." The court concluded that the suit's plaintiffs have not adequately pled loss causation, meaning that the court need not consider Herbalife’s alternative arguments, according to a court filing. Shares of Herbalife are up 3% in pre-market trading after the court dismissal was widely reported by Bloomberg last night.
07:13 EDTHLFHerbalife complaint letter signer subpoenaed, Hartford Courant reports
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use